Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 17
Submit an article Journal homepage
187
Views
22
CrossRef citations to date
0
Altmetric
Review

Pharmacogenomics of multiple sclerosis: in search for a personalized therapy

Iván Martinez-Forero University of Navarra, Center for Applied Medical Research (CIMA), Department of Neuroscience, Neuroimmunology Lab 2.05, 31008 Pamplona, Spain + 34 948 194 700; +34 948 194 715;[email protected]; University of Navarra, Department of Physics and Applied Mathematics, Spain
, MD,
Antonio Pelaez University of Navarra, Department of Physics and Applied Mathematics, Spain
, PhD &
Pablo Villoslada University of Navarra, Center for Applied Medical Research (CIMA), Department of Neuroscience, Neuroimmunology Lab 2.05, 31008 Pamplona, Spain + 34 948 194 700; +34 948 194 715;[email protected]
, MD
Pages 3053-3067 | Published online: 12 Nov 2008

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dorothea Buck & Bernhard Hemmer. (2014) Biomarkers of treatment response in multiple sclerosis. Expert Review of Neurotherapeutics 14:2, pages 165-172.
Read now
John W Rose & Noel G Carlson. (2011) Clinical biomarkers in multiple sclerosis. Expert Opinion on Medical Diagnostics 5:3, pages 213-226.
Read now

Articles from other publishers (20)

María José Zarzuelo Romero, Cristina Pérez Ramírez, María Isabel Carrasco Campos, Almudena Sánchez Martín, Miguel Ángel Calleja Hernández, María Carmen Ramírez Tortosa & Alberto Jiménez Morales. (2021) Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. Journal of Personalized Medicine 11:5, pages 335.
Crossref
Mallahalli. S Manu, Hirohiko Hohjoh & Takashi Yamamura. (2021) Extracellular Vesicles as Pro- and Anti-inflammatory Mediators, Biomarkers and Potential Therapeutic Agents in Multiple Sclerosis. Aging and disease 12:6, pages 1451.
Crossref
Kewal K. JainKewal K. Jain. 2017. The Handbook of Biomarkers. The Handbook of Biomarkers 463 610 .
Kewal K. JainKewal K. Jain. 2015. Textbook of Personalized Medicine. Textbook of Personalized Medicine 409 460 .
Giannina Arru, Stefania Leoni, Maura Pugliatti, Alessandra Mei, Caterina Serra, Lucia Gemma Delogu, Roberto Manetti, Antonina Dolei, Stefano Sotgiu & Giuseppe Mameli. (2013) Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study. Multiple Sclerosis Journal 20:2, pages 174-182.
Crossref
E. M. Medina-Rodríguez, F. J. Arenzana, J. Pastor, M. Redondo, V. Palomo, R. García de Sola, C. Gil, A. Martínez, A. Bribián & F. de Castro. (2013) Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival. Cellular and Molecular Life Sciences 70:18, pages 3449-3462.
Crossref
Kewal K. JainKewal K. Jain. 2013. Applications of Biotechnology in Neurology. Applications of Biotechnology in Neurology 49 153 .
Kewal K. JainKewal K. Jain. 2013. Applications of Biotechnology in Neurology. Applications of Biotechnology in Neurology 575 612 .
Guilherme Sciascia do Olival, Leonardo Ciciarelli Pereira Lima, Gabriel Paiva Silva Lima & Charles Peter Tilbery. (2012) Clinical predictors of response to immunomodulators for multiple sclerosis. Arquivos de Neuro-Psiquiatria 70:1, pages 12-16.
Crossref
Paulo Fontoura & David Leppert. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 272 286 .
. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 56 299 .
Diego Clemente, María Cristina Ortega, Francisco Javier Arenzana & Fernando de Castro. (2011) FGF-2 and Anosmin-1 Are Selectively Expressed in Different Types of Multiple Sclerosis Lesions. The Journal of Neuroscience 31:42, pages 14899-14909.
Crossref
Manuel Comabella & Koen Vandenbroeck. (2011) Pharmacogenomics and Multiple Sclerosis: Moving Toward Individualized Medicine. Current Neurology and Neuroscience Reports 11:5, pages 484-491.
Crossref
Tiffany Tran, Pedro Paz, Sharlene Velichko, Jill Cifrese, Praveen Belur, Ken D. Yamaguchi, Karin Ku, Parham Mirshahpanah, Anthony T. Reder & Ed Croze. (2010) Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling. International Journal of Cell Biology 2010, pages 1-12.
Crossref
Dan MaPaul C Guest & Sabine Bahn. (2009) Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis. Bioanalysis 1:9, pages 1615-1626.
Crossref
Catherine O’Doherty, Alexander Favorov, Shirley Heggarty, Colin Graham, Olga Favorova, Michael Ochs, Stanley Hawkins, Michael Hutchinson, Killian O’Rourke & Koen Vandenbroeck. (2009) Genetic polymorphisms, their allele combinations and IFN-β treatment response in Irish multiple sclerosis patients. Pharmacogenomics 10:7, pages 1177-1186.
Crossref
Koen VandenbroeckManuel Comabella, Eva Tolosa, Robert Goertsches, David Brassat, Rogier Hintzen, Carmen Infante-Duarte, Alexander Favorov, Sergio Escorza, Ricardo Palacios, Jorge R Oksenberg & Pablo Villoslada. (2009) United Europeans for development of pharmacogenomics in multiple sclerosis network. Pharmacogenomics 10:5, pages 885-894.
Crossref
Åge Aleksander SkjevikKnut TeigenAurora Martinez. (2009) Overview of computational methods employed in early-stage drug discovery. Future Medicinal Chemistry 1:1, pages 49-63.
Crossref
Xavier Montalbán. (2009) Multiple sclerosis therapy: historical and future perspectives. Current Opinion in Neurology 22:Suppl 1, pages S1-S3.
Crossref
Kewal K. JainKewal K. Jain. 2009. Textbook of Personalized Medicine. Textbook of Personalized Medicine 255 275 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.